Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
RGDO > SEC Filings for RGDO > Form 8-K on 23-Dec-2013All Recent SEC Filings

Show all filings for REGADO BIOSCIENCES INC

Form 8-K for REGADO BIOSCIENCES INC


23-Dec-2013

Change in Directors or Principal Officers, Financial Statements and Exhibi


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 19, 2013, the Board of Directors (the "Board") of Regado Biosciences, Inc. (the "Company"), based upon the recommendation of the Compensation Committee thereof, approved an amendment to the amended and restated employment agreement between the Company and its Chief Executive Officer, David J. Mazzo, Ph.D. The amendment provides for eligibility for a cash bonus equal to 100% of annual base salary, in lieu of his annual target bonus of 50% of his annual base salary, if certain corporate objectives specified in the amendment are achieved in 2014 or 2015 and certain revisions to the Section 280G cutback provisions in his employment agreement.

The Compensation Committee also approved amendments to the employment agreements for each of the following executive officers: Steven L. Zelenkofske, Christopher Rusconi, Christopher Courts and Alexander R. Gianquinto. These amendments provide for certain revisions to the Section 280G cutback provisions in such officers' employment agreements and, in the case of Mr. Zelenkofske, also provide for reimbursement of reasonable expenses for travel between his place of residence in Pennsylvania and our office in Basking Ridge, New Jersey and for lodging in the Basking Ridge area, of up to $25,000 per year.

The foregoing descriptions of the amendments to the employment agreements for the executive officers are intended to be a summary and are qualified in its entirety by reference to such documents, which are attached as Exhibits 10.1 to 10.5 and are incorporated by reference herein.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit 10.1 -   First Amendment dated December 23, 2013 to Employment Agreement by
                 and between Regado Biosciences, Inc. and David J. Mazzo, dated
                 May 16, 2013.

Exhibit 10.2 -   First Amendment dated December 23, 2013 to Employment Agreement by
                 and between Regado Biosciences, Inc. and Steven L. Zelenkofske,
                 dated May 16, 2013.

Exhibit 10.3 -   First Amendment dated December 23, 2013 to Employment Agreement by
                 and between Regado Biosciences, Inc. and Christopher Rusconi,
                 dated May 16, 2013.

Exhibit 10.4 -   First Amendment dated December 23, 2013 to Employment Agreement by
                 and between Regado Biosciences, Inc. and Christopher E. Courts,
                 dated May 16, 2013.

Exhibit 10.5 -   First Amendment dated December 23, 2013 to Employment Agreement by
                 and between Regado Biosciences, Inc. and Alexander R. Gianquinto,
                 dated May 16, 2013.


  Add RGDO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for RGDO - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.